Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brinster

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Intervirology|August 18, 2001
DNA vaccines for hepatitis C virusC Brinster, G Inchauspé
The Journal of General Virology|January 25, 2002
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particlesC Brinster, M Chen, D Boucreux, et al.
Hepatology (Baltimore, Md.)|December 4, 2001
Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitopeC Brinster, S Muguet, Y C Lone, et al.
Clinical Immunology (Orlando, Fla.)|September 2, 2008
Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cellsG Noël, D Bruniquel, B Birebent, et al.
Virology|October 21, 2000
Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigensO Vidalin, A Fournillier, N Renard, et al.
Journal of Virology|December 13, 2003
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune responseC Rollier, E Depla, J A R Drexhage, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Intervirology|August 18, 2001
DNA vaccines for hepatitis C virusC Brinster, G Inchauspé
The Journal of General Virology|January 25, 2002
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particlesC Brinster, M Chen, D Boucreux, et al.
Hepatology (Baltimore, Md.)|December 4, 2001
Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitopeC Brinster, S Muguet, Y C Lone, et al.
Clinical Immunology (Orlando, Fla.)|September 2, 2008
Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cellsG Noël, D Bruniquel, B Birebent, et al.
Virology|October 21, 2000
Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigensO Vidalin, A Fournillier, N Renard, et al.
Journal of Virology|December 13, 2003
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune responseC Rollier, E Depla, J A R Drexhage, et al.
Pageof 1